Blocking FAO via FAO inhibitor or by CRISPR-mediated CPT1A/CPT2 gene deficiency inhibited radiation-induced ERK activation and aggressive growth and radioresistance of radioresistant breast cancer cells and radiation-derived breast cancer stem cells [114]. Here, CPT2 is linked to breast cancer.